Patent · US Expired

Drug, in particular for modulating the immunological response for the control of viruses, tumors, bacteria and parasites

US7262167B2 · kind B2 · utility

0Cited by

1References

23Claims

0Family size

Assignee

EXiBONA Ltd. · GB

Inventors

Joachim Kalden · Erlangen, DE
Martin Herrmann · Strohberg, DE
Reinhard Voll · Eggolsheim, DE
Wolf Bertling · Erlangen, DE
Klaus von der Mark · Baiersdorf, DE
Otmar Zoller · Kempten, DE

Key dates

Filing date	Aug 11, 2003
Grant date	Aug 28, 2007
Priority date	—
Expiry date	Feb 9, 2025

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A method of treating tumors and other conditions in a patient is provided. The method involves administering to the patient a treatment medicament. The medicament contains a first component and a second component. The first component can be a quantity of tumor cells derived from the patient, and the second component is a quantity of annexin, preferably annexin V. The first component and second component are provided in a therapeutically effective treatment amount. Other conditions can also be treated with annexin.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.